Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd. — Natural Product Compound Library | Innovative Drug Discovery | Spectral Intelligence | Micro-ED Analysis

Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd. Healthy Roots Biotechnology (Shenzhen) Co., Limited Joint Development

中文 EN

Home

Products

NP Database

Services

Tech Insights

About

Contact

中文 EN

Plant Sources

Structural Classes

Microbial Sources

Flagship Varieties

Synthetic Compounds

CAS No.	NAME	Molecular Formula	Molecular Weight	Purity	Price	2D Structure
13650-70-9	tert-Butyl (S)-(-)-lactate CC(C(=O)OC(C)(C)C)O	C₇H₁₄O₃	146.18	98%	Click to inquire
1365267-27-1	(R)-6-Amino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)-N-(4-(4-methylpiperazine-1-carbonyl)phenyl)pyridazine-3-carboxamide CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=CC(=NN=C2N)C(=O)NC3=CC=C(C=C3)C(=O)N4CCN(CC4)C	C₂₅H₂₅Cl₂FN₆O₃	547.4	98%	Click to inquire
1365267-35-1	Urea, N,N'-bis[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]- C1COCC(=O)N1C2=CC=C(C=C2)N3CC(OC3=O)CNC(=O)NCC4CN(C(=O)O4)C5=CC=C(C=C5)N6CCOCC6=O	C₂₉H₃₂N₆O₉	608.6	98%	Click to inquire
1365267-36-2	1,2-Benzenedicarboxamide, N1,N2-bis[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]- C1COCC(=O)N1C2=CC=C(C=C2)N3CC(OC3=O)CNC(=O)C4=CC=CC=C4C(=O)NCC5CN(C(=O)O5)C6=CC=C(C=C6)N7CCOCC7=O	C₃₆H₃₆N₆O₁₀	712.7	98%	Click to inquire
1365267-37-3	Benzoic acid, 2-[[[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]amino]carbonyl]- C1COCC(=O)N1C2=CC=C(C=C2)N3CC(OC3=O)CNC(=O)C4=CC=CC=C4C(=O)O	C₂₂H₂₁N₃O₇	439.4	98%	Click to inquire
136558-13-9	Ethyl 5-(tert-butylthio)-2,2-dimethyl-4-oxopentanoate CCOC(=O)C(C)(C)CC(=O)CSC(C)(C)C	C₁₃H₂₄O₃S	260.39	98%	Click to inquire
1365888-06-7	Brilanestrant CCC(=C(C1=CC=C(C=C1)C=CC(=O)O)C2=CC3=C(C=C2)NN=C3)C4=C(C=C(C=C4)F)Cl	C₂₆H₂₀ClFN₂O₂	446.9	99%	Click to inquire
1365920-11-1	PropanaMide,N-[2-(1,2,6,7-tetrahydro-8H-indeno[5,4-b]furan-8-ylidene)ethyl]- CCC(=O)NCC=C1CCC2=C1C3=C(C=C2)OCC3	C₁₆H₁₉NO₂	257.33	98%	Click to inquire
136668-42-3	Quiflapon CC(C)(C)SC1=C(N(C2=C1C=C(C=C2)OCC3=NC4=CC=CC=C4C=C3)CC5=CC=C(C=C5)Cl)CC(C)(C)C(=O)O	C₃₄H₃₅ClN₂O₃S	587.2	95%	Click to inquire
136676-91-0	PD 123319 ditrifluoroacetate CC1=C(C=CC(=C1)CN2C=NC3=C2CC(N(C3)C(=O)C(C4=CC=CC=C4)C5=CC=CC=C5)C(=O)O)N(C)C.C(=O)(C(F)(F)F)O.C(=O)(C(F)(F)F)O	C₃₅H₃₄F₆N₄O₇	736.7	99%	Click to inquire

tert-Butyl (S)-(-)-lactate

tert-Butyl L-lactate

C₇H₁₄O₃ 146.18

(R)-6-Amino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)-N-(4-(4-methylpiperazine-1-carbonyl)phenyl)pyridazine-3-carboxamide

C₂₅H₂₅Cl₂FN₆O₃ 547.4

Urea, N,N'-bis[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-

Urea, N,N'-bis[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-

C₂₉H₃₂N₆O₉ 608.6

1,2-Benzenedicarboxamide, N1,N2-bis[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-

Rivaroxaban Impurity IV (Potential Impurity)

C₃₆H₃₆N₆O₁₀ 712.7

Benzoic acid, 2-[[[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]amino]carbonyl]-

Rivaroxaban Impurity V (Potential Impurity)

C₂₂H₂₁N₃O₇ 439.4

Ethyl 5-(tert-butylthio)-2,2-dimethyl-4-oxopentanoate

Ethyl 5-tert-Butylthio-2,2-dimethyl-4-oxopentanoate

C₁₃H₂₄O₃S 260.39

C₂₆H₂₀ClFN₂O₂ 446.9

PropanaMide,N-[2-(1,2,6,7-tetrahydro-8H-indeno[5,4-b]furan-8-ylidene)ethyl]-

Propanamide, N-[2-(1,2,6,7-tetrahydro-8H-indeno[5,4-b]furan-8-ylidene)ethyl]-

C₁₆H₁₉NO₂ 257.33

C₃₄H₃₅ClN₂O₃S 587.2

PD 123319 ditrifluoroacetate

PD123319 Ditrifluoroacetate

C₃₅H₃₄F₆N₄O₇ 736.7

< Previous 1 2 3 4 5 6 7 8 9 10 ... (Current page 15218) 16106 Next >

All products and services are for scientific research only. They may not be used for human administration, nor are they supplied to individual consumers.

Address: Room B410, Virtual University Park Key Laboratory Building, No. 1 Yuexing 2nd Road, High-Tech Zone Community, Yuehai Subdistrict, Nanshan District, Shenzhen

Phone: 400-856-5689

Email: kehuaai@kehuaai.com

Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd.

ICP Record No.: 粤ICP备2024241782号